DOI QR코드

DOI QR Code

The Clinical Features of Spinal Leptomeningeal Dissemination from Malignant Gliomas

  • Bae, Jung-Sik (Department of Neurosurgery, Seoul St. Mary's Hospital, The Catholic University of Korea) ;
  • Yang, Seung-Ho (Department of Neurosurgery, St. Vincent Hospital, The Catholic University of Korea) ;
  • Yoon, Woan-Soo (Department of Neurosurgery, Incheon St. Mary's Hospital, The Catholic University of Korea) ;
  • Kang, Seok-Gu (Department of Neurosurgery, Seoul St. Mary's Hospital, The Catholic University of Korea) ;
  • Hong, Yong-Kil (Department of Neurosurgery, Seoul St. Mary's Hospital, The Catholic University of Korea) ;
  • Jeun, Sin-Soo (Department of Neurosurgery, Seoul St. Mary's Hospital, The Catholic University of Korea)
  • Received : 2010.09.18
  • Accepted : 2011.05.30
  • Published : 2011.06.28

Abstract

Objective : The incidence of leptomeningeal dissemination from malignant glioma is rare, so the clinical features of this are not well documented yet We attempted to determine the clinical features of leptomeningeal dissemination from malignant gliomas. Methods : We retrospectively analyzed 11 cases of leptomeningeal dissemination of malignant glioma, who were treated at our institution between 2006 and 2009. We investigated the clinical features of these patients by considering the following factors : tumor locations, the events of ventricular opening during surgery and the cerebrospinal fluid (CSF) profiles, including the cytology. Results : The group was composed of 9 males and 2 females. The histological diagnosis of their initial intracranial tumors were 4 primary glioblastoma, 3 anaplastic astrocytoma, 1 anaplastic oligoastrocytoma, 2 ganglioglioma and 1 pleomorphic xanthoastrocyotma with anaplastic features. The mean age of the patients at the time of the initial presentation was $42.8{\pm}10.3$ years. The mean time between surgery and the diagnosis of spinal dissemination was $12.3{\pm}7.9$ (3-28) months. The mean overall survival after dissemination was $2.7{\pm}1.3$ months. All our patients revealed a history of surgical opening of the ventricles. Elevated protein in the CSF was reported for eight patients who had their CSF profiles checked. Conclusion : We propose that in the malignant gliomas, the surgical opening of ventricles can cause the spinal leptomeningeal dissemination and the elevated protein content of CSF may be a candidate marker of leptomeningeal dissemination.

Keywords

References

  1. Alatakis S, Malham GM, Thien C : Spinal leptomeningeal metastasis from cerebral glioblastoma multiforme presenting with radicular pain. Surg Neurol 56 : 33-37; discussion 37-38, 2001 https://doi.org/10.1016/S0090-3019(01)00459-1
  2. Arita N, Taneda M, Hayakawa T : Leptomeningeal dissemination of malignant gliomas. Incidence, diagnosis, and outcome. Acta Neurochir (Wien) 126 : 84-92, 1994 https://doi.org/10.1007/BF01476415
  3. Balhuizen JC, Bots GT, Schaberg A, Bosman FT : Value of cerebrospinal fluid cytology for the diagnosis of malignancies in the central nervous system. J Neurosurg 48 : 747-753, 1978 https://doi.org/10.3171/jns.1978.48.5.0747
  4. Bigner SH, Johnston WW : The cytopathology of cerebrospinal fluid. II. Metastatic cancer, meningeal carcinomatosis and primary central nervous system neoplasms. Acta Cytol 25 : 461-479, 1981
  5. Bryan P : CSF seeding of intracranial tumors : a study of 96 cases. Clin Radiol 25 : 355-360, 1974 https://doi.org/10.1016/S0009-9260(74)80168-6
  6. Choucair AK, Levin VA, Gutin PH, Davis RL, Silver BA, Edwards MS, et al. : Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas. J Neurosurg 65 : 654-658, 1986 https://doi.org/10.3171/jns.1986.65.5.0654
  7. Elliott JP, Keles GE, Waite M, Temkin N, Berger MS : Ventricular entry during resection of malignant gliomas : effect on intracranial cerebrospinal fluid tumor dissemination. J Neurosurg 80 : 834-839, 1994 https://doi.org/10.3171/jns.1994.80.5.0834
  8. Erlich SS, Davis RL : Spinal subarachnoid metastasis from primary intracranial glioblastoma multiforme. Cancer 42 : 2854-2864, 1978 https://doi.org/10.1002/1097-0142(197812)42:6<2854::AID-CNCR2820420647>3.0.CO;2-4
  9. Grabb PA, Albright AL, Pang D : Dissemination of supratentorial malignant gliomas via the cerebrospinal fluid in children. Neurosurgery 30 : 64-71, 1992 https://doi.org/10.1227/00006123-199201000-00012
  10. Han SR, Yee GT, Lee DJ, Whang CJ : Spinal metastases from supratentorial glioblastoma. J Korean Neurosurg Soc 38 : 475-477, 2005
  11. Karnofsky DA, Burchenal JH : The clinical evaluation of chemotherapeutic agents in cancer in Macleod CM (ed) : Evaluation of Chemotherapeutic Agents. New York : Columbia University Press, 1949, pp 191-205
  12. Lee YY, Glass JP, Geoffray A, Wallace S : Cranial computed tomographic abnormalities in leptomeningeal metastasis. AJR Am J Roentgenol 143 : 1035-1039, 1984 https://doi.org/10.2214/ajr.143.5.1035
  13. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG : Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8 : 1277-1280, 1990
  14. Onda K, Tanaka R, Takahashi H, Takeda N, Ikuta F : Symptomatic cerebrospinal fluid dissemination of cerebral glioblastoma. Computed tomography findings in 11 cases. Neuroradiology 32 : 146-150, 1990 https://doi.org/10.1007/BF00588565
  15. Packer RJ, Siegel KR, Sutton LN, Litmann P, Bruce DA, Schut L : Leptomeningeal dissemination of primary central nervous system tumors of childhood. Ann Neurol 18 : 217-221, 1985 https://doi.org/10.1002/ana.410180209
  16. Saito R, Kumabe T, Jokura H, Shirane R, Yoshimoto T : Symptomatic spinal dissemination of malignant astrocytoma. J Neurooncol 61 : 227-235, 2003 https://doi.org/10.1023/A:1022536828345
  17. Salazar OM, Rubin P : The spread of glioblastoma multiforme as a determining factor in the radiation treated volume. Int J Radiat Oncol Biol Phys 1 : 627-637, 1976 https://doi.org/10.1016/0360-3016(76)90144-9
  18. Vertosick FT Jr, Selker RG : Brainstem and spinal metastases of supratentorial glioblastoma multiforme : a clinical series. Neurosurgery 27 : 516-521; discussion 521-522, 1990 https://doi.org/10.1227/00006123-199010000-00002
  19. Vredenburgh JJ, Desjardins A, Herndon JE 2nd, Marcello J, Reardon DA, Quinn JA, et al. : Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 25 : 4722-4729, 2007 https://doi.org/10.1200/JCO.2007.12.2440
  20. Yung WA, Horten BC, Shapiro WR : Meningeal gliomatosis : a review of 12 cases. Ann Neurol 8 : 605-608, 1980 https://doi.org/10.1002/ana.410080610

Cited by

  1. Incidence and Risk Factors for Leptomeningeal Carcinomatosis in Breast Cancer Patients with Parenchymal Brain Metastases vol.52, pp.3, 2012, https://doi.org/10.3340/jkns.2012.52.3.193
  2. Clinical Characteristics and Neuroimaging Findings in 12 Cases of Recurrent Glioblastoma With Communicating Hydrocephalus vol.53, pp.7, 2011, https://doi.org/10.2176/nmc.53.474
  3. Leptomeningeal Metastases in High-Grade Adult Glioma: Development, Diagnosis, Management, and Outcomes in a Series of 34 Patients vol.5, pp.None, 2011, https://doi.org/10.3389/fneur.2014.00220
  4. Surgical Ventricular Entry is a Key Risk Factor for Leptomeningeal Metastasis of High Grade Gliomas vol.5, pp.None, 2015, https://doi.org/10.1038/srep17758
  5. Endoscopic diagnosis of an MRI-occult, low-grade glioma with ependymal dissemination vol.16, pp.4, 2015, https://doi.org/10.3171/2015.3.peds14444
  6. Histopathological implications of ventricle wall 5-aminolevulinic acid-induced fluorescence in the absence of tumor involvement on magnetic resonance images vol.36, pp.2, 2011, https://doi.org/10.3892/or.2016.4881
  7. Addition of Anti-Angiogenetic Therapy with Bevacizumab to Chemo- and Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors vol.11, pp.6, 2011, https://doi.org/10.1371/journal.pone.0155315
  8. Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma vol.9, pp.373, 2011, https://doi.org/10.1126/scitranslmed.aag2196
  9. Response of Leptomeningeal Dissemination of Anaplastic Glioma to Temozolomide: Experience of Two Cases vol.5, pp.2, 2011, https://doi.org/10.14791/btrt.2017.5.2.99
  10. Neoplastic Myelopathies : vol.24, pp.2, 2011, https://doi.org/10.1212/con.0000000000000585
  11. Extensive Pachymeningeal Dissemination of Glioblastoma Mimicking Chronic Subdural Hematoma: A Case Report vol.7, pp.1, 2011, https://doi.org/10.14791/btrt.2019.7.e24
  12. Modern operative nuances for the management of eloquent high-grade gliomas vol.63, pp.2, 2011, https://doi.org/10.23736/s0390-5616.18.04594-0
  13. Diagnosis, treatment, and survival in spinal dissemination of primary intracranial glioblastoma: systematic literature review vol.31, pp.5, 2011, https://doi.org/10.3171/2019.5.spine19164
  14. Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges vol.25, pp.11, 2011, https://doi.org/10.1634/theoncologist.2020-0258
  15. A Retrospective Study on Spinal Dissemination of Supratentorial Glioma vol.11, pp.None, 2011, https://doi.org/10.3389/fonc.2021.765399